Anderson N - Search Results

1

Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas.

Lokich J, Anderson N, Moore C, Bern M, Coco F, Sonneborn H, Dow E, Strong D. Lokich J, et al. Among authors: anderson n. Eur J Cancer. 1998 Apr;34(5):664-7. doi: 10.1016/s0959-8049(97)10108-3. Eur J Cancer. 1998. PMID: 9713271

2

Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.

Lokich J, Anderson N, Coco F. Lokich J, et al. Among authors: anderson n. Cancer Invest. 2003;21(6):830-6. doi: 10.1081/cnv-120025085. Cancer Invest. 2003. PMID: 14735686 Clinical Trial.

3

Pilot study of ambulatory infusional ifosfamide admixed with carboplatin.

Lokich JJ, Zipoli TE, Anderson NR, Moore C, Gonzalves L, Bern MM, Coco F. Lokich JJ, et al. Among authors: anderson nr. Cancer. 1993 Mar 15;71(6):2072-5. doi: 10.1002/1097-0142(19930315)71:6<2072::aid-cncr2820710623>3.0.co;2-x. Cancer. 1993. PMID: 8443756 Clinical Trial.

4

Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.

Lokich JJ, Moore CL, Anderson NR. Lokich JJ, et al. Among authors: anderson nr. Cancer. 1996 Jul 15;78(2):294-9. doi: 10.1002/(SICI)1097-0142(19960715)78:2<294::AID-CNCR16>3.0.CO;2-R. Cancer. 1996. PMID: 8674006

5

Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.

Lokich JJ, Moore CL, Anderson NR. Lokich JJ, et al. Among authors: anderson nr. Cancer. 1996 Jul 15;78(2):300-3. doi: 10.1002/(SICI)1097-0142(19960715)78:2<300::AID-CNCR17>3.0.CO;2-#. Cancer. 1996. PMID: 8674007

6

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.

Lokich JJ, Sonneborn H, Anderson NR, Bern MM, Coco FV, Dow E, Oliynyk P. Lokich JJ, et al. Among authors: anderson nr. Cancer. 1999 Jun 1;85(11):2347-51. doi: 10.1002/(sici)1097-0142(19990601)85:11<2347::aid-cncr8>3.0.co;2-8. Cancer. 1999. PMID: 10357404 Clinical Trial.

7

Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.

Lokich J, Anderson N, Bern M, Zipoli T, Gonsalves L, Moore C. Lokich J, et al. Among authors: anderson n. Am J Clin Oncol. 1992 Aug;15(4):314-8. doi: 10.1097/00000421-199208000-00008. Am J Clin Oncol. 1992. PMID: 1514527 Clinical Trial.

8

Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons.

Anderson N, Lokich J. Anderson N, et al. Cancer. 1992 Aug 15;70(4 Suppl):998-1002. Cancer. 1992. PMID: 1638471 Review.

9

Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.

Lokich J, Moore C, Anderson N, Bern M. Lokich J, et al. Among authors: anderson n. Eur J Cancer. 1991;27(12):1593-6. doi: 10.1016/0277-5379(91)90421-9. Eur J Cancer. 1991. PMID: 1838261

10

Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.

Lokich J, Anderson N, Bern M, Coco F, Zipoli T, Moore C, Gonsalves L. Lokich J, et al. Among authors: anderson n. Cancer. 1991 Aug 15;68(4):744-6. doi: 10.1002/1097-0142(19910815)68:4<744::aid-cncr2820680414>3.0.co;2-r. Cancer. 1991. PMID: 1855174 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,769 results

Search Page

Filters